216 learners taking this course
In the 1980’s naltrexone was FDA approved for the treatment of opiate addiction and in 1995 it received approval for the treatment of alcohol withdrawal. However, low-dose naltrexone (LDN) has recently shown dramatic benefit in patients with autoimmune conditions, cancer, HIV/AIDS, and central nervous system disorders. This 1 hour webinar will review how LDN works and what chronic illnesses it has been shown to improve. Side effects, dosages, and how it is prepared will also be discussed.
- Understand how LDN works
- Identify which diseases LDN is effective for
- Identify side effects and cautionary warnings
- Understand how LDN is prepared